O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P84022 |
SMAD3_HUMAN |
Herpes simplex infection [ICD-11: 1F00] |
P84022 |
SMAD3_HUMAN |
Kidney fibrosis [ICD-11: GC01] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P37840 |
SYUA_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P37840 |
SYUA_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P37840 |
SYUA_HUMAN |
Autonomic nervous system disorder [ICD-11: 8D87] |
Q13148 |
TADBP_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
Q13148 |
TADBP_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q96KQ7 |
EHMT2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 |
EHMT2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 |
EHMT2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P42858 |
HD_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P51151 |
RAB9A_HUMAN |
Fungal infection [ICD-11: 1F29-1F2F] |
P04637 |
P53_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P04637 |
P53_HUMAN |
Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
P04637 |
P53_HUMAN |
Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
P04637 |
P53_HUMAN |
Transplant rejection [ICD-11: NE84] |
P04637 |
P53_HUMAN |
Ovarian dysfunction [ICD-11: 5A80] |
P04637 |
P53_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 |
P53_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P04637 |
P53_HUMAN |
Brain cancer [ICD-11: 2A00] |
P04637 |
P53_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P04637 |
P53_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P04637 |
P53_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P04637 |
P53_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P04637 |
P53_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P04637 |
P53_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P04637 |
P53_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P04637 |
P53_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 |
P53_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P04637 |
P53_HUMAN |
Cervical cancer [ICD-11: 2C77] |
P04637 |
P53_HUMAN |
Endometrial cancer [ICD-11: 2C76] |
P04637 |
P53_HUMAN |
Fallopian tube cancer [ICD-11: 2C74] |
P04637 |
P53_HUMAN |
Liposarcoma [ICD-11: 2B59] |
P04637 |
P53_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P04637 |
P53_HUMAN |
Peritoneal cancer [ICD-11: 2C51] |
P04637 |
P53_HUMAN |
Toxicity [ICD-11: N.A.] |
P04637 |
P53_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 |
P53_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 |
P53_HUMAN |
Kidney failure [ICD-11: GB60-GB6Z] |
P04637 |
P53_HUMAN |
Hearing disorder [ICD-11: AB50-AB57] |